Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Ajinomoto reports on antihypertensive agent AP-1067

May 3, 1996

More research into angiotensin II antagonists at Takeda

May 3, 1996

Takeda discovers new PGDF inhibitors

May 3, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Japanese investigators reveal new agent for heart failure

April 26, 1996

BMS-193884 in development for heart failure

April 26, 1996

Class III antiarrhythmic presented by Japanese academics

April 26, 1996

GP-531 enters phase II

April 26, 1996

Antirestenosis agents reported by Fujisawa, Teijin

April 26, 1996

BMS-191095 in phase I for ischemia

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...